跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,067 条关于
“TIMI”
全部
6,067
临床试验
4,657
药物
45
机构
6
资讯
1,359
去年
DAPA ACT HF-TIMI 68 Trial Shows Promise for In-Hospital SGLT2 Inhibitor Initiation Despite Missing Primary Endpoint
去年
LILAC-TIMI 76 Trial Evaluates Factor XI Inhibitor for Atrial Fibrillation Patients
去年
Abelacimab Shows Promise in Reducing Bleeding Risk for Atrial Fibrillation Patients
3个月前
SGLT2 Inhibitors in Acute Heart Failure: Early Initiation After Stabilization Gains Guideline Support, Though Key Questions Remain
3个月前
Dapagliflozin Reduces Heart Failure Risk by 82% in Carriers of Cardiomyopathy Genetic Variants
去年
Abelacimab Shows Low Bleeding Rates in Phase 2 Periprocedural Trial, May Simplify Anticoagulation Management
去年
Olezarsen Achieves 60% Triglyceride Reduction in Phase 3 Trial for Cardiovascular Risk Patients
3年前
Merck Launches First Phase 3 Program for Oral PCSK9 Inhibitor MK-0616 to Treat High Cholesterol
去年
ESC Congress 2025 to Showcase Pivotal Cardiovascular Trials with Global Health Impact
去年
Ionis Reports Positive Phase 3 Results for Olezarsen in Hypertriglyceridemia
第 1 页,共 136 页
上一页
下一页